I believe that’s the the public money they have spent but not recovered from the revenue . That doesn’t mean they owe anyone 1.3B. That money was provided by the public/investors through all the raises and dilutions etc Please correct me if I am wrong
DocLee, you’re unlikely to see a number specifically for total DCVax development costs. The accumulated deficit is generally accepted as a reasonable public number for the costs spent by the company to date, since revenues have been extremely minimal, but it does include other expenses to run the company, in addition to the specific drug development costs.